Skip to content

In HIV patients with lipoatrophy, antioxidants lead to only modest improvement in LDL cholesterol

Warning on atazanavir and tenofovir combination

Editorial attacks shift away from condoms in HIV prevention

Hazardous drinking widespread in HIV-positive US veterans

Few HIV-positive Americans vaccinated against HBV and 7% coinfected with HIV/HBV

Over a third of syphilis cases in Manchester involve HIV-positive gay men and oral sex key to spread

Efavirenz, indinavir and abacavir most potent antiretrovirals in pre-2001 study

Short-term cannabis use does not lead to increase in HIV viral load or impairment of immune system

High adherence leads to more drug resistance in patients with incomplete HIV suppression

T-20 for post-exposure prophylaxis?

Six months of DOT achieves undetectable HIV viral load in both genital tract and plasma

Initial HAART regimen lasts only 1.6 years in antiretroviral-naive

Computer model says vaccines and treatment both needed to turn tide of HIV

Success and failure in HIV treatment: contrasting lessons from South Africa

HAART optimism means HIV-positive IV drug users more likely to have unsafe sex and share needles

Nevirapine for PEP: should use be restricted due to liver toxicity risk?

Treatment interruption shows no benefit in HIV patients with drug resistance

New US HIV lipid guidelines favour lifestyle changes over drug therapy as first line